1. |
[1]Emanuel EJ, Miller FG. The ethics of placebo-controlled trials-a middle ground[J]. N Eng J Med 2001 ;345:915-919.
|
2. |
[2]World Medical Association. Declaration of Helsinki V: Ethical principles for medical research involving human subjects. 52ndWorld Medical Assembly, Edinburgh, Scotland, October 2000.
|
3. |
[3]World Medical Association. Note of clarification on paragraph 29 of the WMA Declaration of Helsinki. October 2001.
|
4. |
[4]Temple R. Government viewpoint of clinical trials[J]. Drug Information J 1982; 16:10-17.
|
5. |
[5]Freedman B. Equipoise and the ethics of clinical research[J]. N Eng J Med 1987;317:141-145.
|
6. |
[6]Huston P, Peterson R. Withholding proven treatment in clinical research[J]. N Eng J Med 2001;345:912-914.
|
7. |
[7]Rothman KJ, Michels KB, Baum M. For and against: Declaration of Helsinki should be strengthened[J]. BMJ 2000;321:442-444.
|
8. |
[8]Rothman KJ, Michels KB. The continuing unethical use of placebo controls[J]. N Eng J Med 1994;331:455-463.
|
9. |
[9]Forster HP, Emanuel E, Grady C. The 2000 revision of the Declaration of Helsinki: a step forward or more confusion[J]? Lancet 2001 ;358:1449-1453.
|
10. |
[10]Turner JA, Deyo RA, Lieser JD et al. The importance of placebo effects in pain treatment and research[J]. JAMA 1994;271:1609-1614.
|
11. |
[11]Simon R. Are placebo-controlled clinical trials ethical or needed when alternative treatment exists[J]? Ann Intern Med 2000;133:474-475.
|
12. |
[12]Reynolds T. The ethics of placebo-controlled trials[J]. Ann Intern Med 2000; 133:491-492.
|
13. |
[13]Vastag B. Helsinki discord? A controversial Declaration[J]. JAMA 2000;284:2983-2985.
|
14. |
[14]Temple R, Ellenberg SS. Placebo-controlled trials and activecontrolled trials in the evaluation of new treatment. Part 1: ethical and scientific issues[J]. Ann Intern Med 2000;133:455-463.
|
15. |
[15]ICH Steering Committee. ICH harmonized tripartite guideline:Choice of control group and related issues in clinical trials. July 2000.
|
16. |
[16]The European Agency for the Evaluation of Medicinal Products, Preauthorization evaluation of medicines for human use. EMEA/CPMP position statement on the use of placebo in clinical trials with regard to the revised Declaration of Helsinki. EMEA2001;17424/01.
|
17. |
[17]Orentlicher D. Placebo-controlled trials of new drugs: ethical considerations[J]. Diabetes Care 2001;24:771-772.
|
18. |
[18]Simon R. Are placebo-controlled trials ethical or needed when alternative treatment exists[J]? Ann Intern Med 2000;166:474-475.
|
19. |
[19]Vickers A, de Craen AJM. Why use placebos in clinical trials? A narrative review of the methodological literature[J]. J Clin Epidemiology 2000;53:157-161.
|
20. |
[20]Benson H, Friedman R. Harnessing the power of the placebo effect and renaming it "remembered wellness" [J]. Annue Rev Med 1996;47:193-199.
|
21. |
[21]Roberts LW, Lauriello J, Geppert C, Keith SJ. Placebos and paradoxes in psychiatric research: an ethics perspective[J]. Biol Psychiatry 2001 ;49:887-893.
|
22. |
[22]Leber P. The placebo control in clinical trials (a view from the FDA)[J]. Psychopharmacol Bull 1986;22:30-32.
|
23. |
[23]Weihrauch TR, Gauler TC. Placebo-efficacy and adverse effects in controlled clinical trials[J]. Arzneimittelforschung 1999;49:385-393.
|
24. |
[24]Khan A, Warner HA, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials[J]. 2000;57:311-317.
|
25. |
[25]Storosum JG, van Zwieten B J, van den Brink W, Gersons BPR,Broekman AW. Suicide risk in placebo-controlled studies of major depression[J]. Am J Psychiatry 2001; 158:1271 - 1275.
|
26. |
[26]Collins R, Peto R, MacMahon S. et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context[J]. Lancet 1990;335:827-38.
|
27. |
[27]Al-Khatib SM, Califf RM, Hasselblad V, Alexander JH, McCrory DC, Sugarman J. Placebo-controls in short-term clinical trials of hypertension[J]. Science 2001; 292:2013-2015.
|
28. |
[28]Bell DSH. Ethics in diabetic clinical trials[J]. Diabetes Care 2001 ;24:606.
|
29. |
[29]Shapiro HT, Meslin EM. Ethical issues in the design and conduct of clinical trials in developing countries[J]. N Eng J Med 2001;345:139-141.
|